Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow-to-Debt Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥110.78 Million could theoretically repay 0% of its total liabilities (CN¥2.56 Billion) in one year. See 600329 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Tianjin Zhongxin Pharmaceutical Group Co.
Annual Cash Flow-to-Debt Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. Check Tianjin Zhongxin Pharmaceutical Group Co (600329) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥924.67 Million | CN¥2.92 Billion | ▲ +65.0% |
| 2023 | 0.19x | CN¥688.49 Million | CN¥3.58 Billion | ▲ +2.2% |
| 2022 | 0.19x | CN¥677.25 Million | CN¥3.61 Billion | ▼ -43.7% |
| 2021 | 0.33x | CN¥852.40 Million | CN¥2.55 Billion | ▲ +16.0% |
| 2020 | 0.29x | CN¥671.42 Million | CN¥2.33 Billion | ▲ +34.7% |
| 2019 | 0.21x | CN¥495.49 Million | CN¥2.32 Billion | ▲ +25.1% |
| 2018 | 0.17x | CN¥350.14 Million | CN¥2.05 Billion | ▲ +8679.3% |
| 2017 | 0.00x | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -101.0% |
| 2016 | 0.20x | CN¥419.90 Million | CN¥2.06 Billion | ▲ +11.1% |
| 2015 | 0.18x | CN¥360.58 Million | CN¥1.96 Billion | ▲ +59.4% |
| 2014 | 0.12x | CN¥286.85 Million | CN¥2.49 Billion | ▲ +45.0% |
| 2013 | 0.08x | CN¥213.44 Million | CN¥2.69 Billion | ▲ +717.4% |
| 2012 | 0.01x | CN¥20.81 Million | CN¥2.14 Billion | ▼ -89.2% |
| 2011 | 0.09x | CN¥173.88 Million | CN¥1.94 Billion | ▲ +12.9% |
| 2010 | 0.08x | CN¥139.04 Million | CN¥1.75 Billion | ▲ +79.0% |
| 2009 | 0.04x | CN¥83.41 Million | CN¥1.88 Billion | ▼ -43.8% |
| 2008 | 0.08x | CN¥155.77 Million | CN¥1.97 Billion | ▲ +734.4% |
| 2007 | 0.01x | CN¥20.13 Million | CN¥2.13 Billion | ▲ +170.7% |
| 2006 | -0.01x | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -110.8% |
| 2005 | 0.12x | CN¥261.91 Million | CN¥2.11 Billion | ▲ +2310.9% |
| 2004 | 0.01x | CN¥10.50 Million | CN¥2.04 Billion | ▼ -86.8% |
| 2003 | 0.04x | CN¥76.57 Million | CN¥1.96 Billion | ▼ -72.5% |
| 2002 | 0.14x | CN¥187.60 Million | CN¥1.32 Billion | ▲ +6.3% |
| 2001 | 0.13x | CN¥157.73 Million | CN¥1.18 Billion | — |